We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBCT
226
DELISTED
People's United Financial Inc
PBCT
$197K 0.02%
11,727
+158
+1% +$2.62K
F icon
227
Ford
F
$56.7B
$187K 0.02%
18,317
-539
-3% -$5.31K
HPE icon
228
Hewlett Packard
HPE
$60.7B
$152K 0.01%
10,159
+8
+0.1% +$121
CNST
229
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$151K 0.01%
12,262
– –
EVV
230
Eaton Vance Limited Duration Income Fund
EVV
$1.08B
$139K 0.01%
10,994
– –
AEG icon
231
Aegon
AEG
$13.3B
$136K 0.01%
30,980
+12,526
+68% +$53.3K
SIRI icon
232
SiriusXM
SIRI
$10.3B
$112K 0.01%
2,000
+40
+2% +$2.27K
CTACU
233
DELISTED
ChaSerg Technology Acquisition Corp. Unit
CTACU
$102K 0.01%
10,000
– –
ALSK
234
DELISTED
Alaska Communications Systems
ALSK
$17K ﹤0.01%
10,000
– –
CCI icon
235
Crown Castle
CCI
$34.6B
– –
-69,942
Closed -$8.95M
ELV icon
236
Elevance Health
ELV
$80.9B
– –
-956
Closed -$274K
FISV
237
Fiserv Inc
FISV
$27B
– –
-2,391
Closed -$211K
IBB icon
238
iShares Biotechnology ETF
IBB
$9.23B
– –
-1,953
Closed -$218K
LOW icon
239
Lowe's Companies
LOW
$117B
– –
-4,314
Closed -$472K
NEN icon
240
New England Realty Associates
NEN
– –
-3,187
Closed -$208K
SNOA icon
241
Sonoma Pharmaceuticals
SNOA
$5.79M
– –
-61
Closed -$10K
VIG icon
242
Vanguard Dividend Appreciation ETF
VIG
$111B
– –
-1,994
Closed -$219K
VTV icon
243
Vanguard Value ETF
VTV
$186B
– –
-2,408
Closed -$259K
6 7 8 9
10

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.